Robert T. Davis Jr. - Mar 1, 2023 Form 4 Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Role
EVP & President, TT
Signature
/s/ Eric Schwartz; Attorney-in-Fact
Stock symbol
IART
Transactions as of
Mar 1, 2023
Transactions value $
-$44,392
Form type
4
Date filed
3/3/2023, 04:20 PM
Previous filing
Feb 15, 2023
Next filing
Mar 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IART Common Stock Options Exercise $42.1K +1.57K +3.41% $26.87 47.5K Mar 1, 2023 Direct
transaction IART Common Stock Sale -$86.5K -1.57K -3.3% $55.21 45.9K Mar 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IART Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.57K -100% $0.00* 0 Mar 1, 2023 Common Stock 1.57K $26.87 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $55.2118 to $55.22. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
F2 25% of the stock options vested every first, second, third and fourth anniversaries of the grant date of 03/23/2015.